[
  {
    "ts": null,
    "headline": "Allspring Core Bond Fund Q4 2024 Commentary",
    "summary": "The Bloomberg U.S. Aggregate Bond Index fell 3.06% for the fourth quarter of 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=b879ca5e4a053675da186ef8a8be70090e5cf277f8c3b58960206b24a65e48d3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740166200,
      "headline": "Allspring Core Bond Fund Q4 2024 Commentary",
      "id": 132830638,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2153767985/image_2153767985.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "The Bloomberg U.S. Aggregate Bond Index fell 3.06% for the fourth quarter of 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=b879ca5e4a053675da186ef8a8be70090e5cf277f8c3b58960206b24a65e48d3"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "summary": "Pfizer Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=5a366e47a79266088cb712811f1ed62149395cee94bc7516ae89cd0cf562026f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740155760,
      "headline": "Pfizer Inc. stock underperforms Friday when compared to competitors despite daily gains",
      "id": 132837466,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock underperforms Friday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=5a366e47a79266088cb712811f1ed62149395cee94bc7516ae89cd0cf562026f"
    }
  },
  {
    "ts": null,
    "headline": "Past Week Dominated By Corporate Earnings Stories",
    "summary": "Past week dominated by good news and a few corporate earnings.",
    "url": "https://finnhub.io/api/news?id=75b7ae5d20612a575b8a1ac3b3c041a75ae3684efda3556f93504b7f3028f83f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740149100,
      "headline": "Past Week Dominated By Corporate Earnings Stories",
      "id": 132829606,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/160616076/image_160616076.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Past week dominated by good news and a few corporate earnings.",
      "url": "https://finnhub.io/api/news?id=75b7ae5d20612a575b8a1ac3b3c041a75ae3684efda3556f93504b7f3028f83f"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Investors Won't Stick Around Forever",
    "summary": "Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain momentum in the near term.",
    "url": "https://finnhub.io/api/news?id=64cfbe1b5fb3695fa881b11d2d3742015a6822aa4d22ae93ecb6a230d85d449c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740137400,
      "headline": "Pfizer: Investors Won't Stick Around Forever",
      "id": 132828704,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491484031/image_1491484031.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain momentum in the near term.",
      "url": "https://finnhub.io/api/news?id=64cfbe1b5fb3695fa881b11d2d3742015a6822aa4d22ae93ecb6a230d85d449c"
    }
  }
]